Patents Assigned to MYBIOTICS PHARMA LTD.
  • Patent number: 11679136
    Abstract: The present invention provides a composition comprising a co-culture of at least two distinct bacterial families, having differing growth and/or proliferative conditions. In some embodiments, the composition comprises a plurality of bacterial genera with high similarity to microbial flora.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: June 20, 2023
    Assignee: MYBIOTICS PHARMA LTD.
    Inventors: David Baram, David Daboush, Rachel Diamant
  • Patent number: 11680257
    Abstract: The present invention provides a method, wherein the method forms a biofilm, wherein the biofilm comprises a population of at least one bacterial strain attached to particles, wherein the biofilm is configured to colonize a gut of a subject in need thereof for at least five days, when ingested by the subject, the method comprising: a. obtaining a population comprising at least one strain of bacteria; b. inoculating a growth medium containing particles with the population comprising at least one strain of bacteria; c. incubating the particles with the population comprising at least one bacterial strain for a time sufficient for the population of at least one strain of bacteria to attach to the particles; and d. culturing the population comprising at least one strain of bacteria attached to the particles in a growth medium, for a time sufficient to form a biofilm.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: June 20, 2023
    Assignee: MYBIOTICS PHARMA LTD.
    Inventors: David Baram, Rachel Diamant, David Daboush
  • Patent number: 11123383
    Abstract: The present invention provides a composition comprising a co-culture of at least two distinct bacterial families, having differing growth and/or proliferative conditions. In some embodiments, the composition comprises a plurality of bacterial genera with high similarity to microbial flora.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: September 21, 2021
    Assignee: MYBIOTICS PHARMA LTD.
    Inventors: David Baram, David Daboush, Rachel Diamant
  • Patent number: 11001828
    Abstract: The present invention provides a method, wherein the method forms a biofilm, wherein the biofilm comprises a population of at least one bacterial strain attached to particles, wherein the biofilm is configured to colonize a gut of a subject in need thereof for at least five days, when ingested by the subject, the method comprising: a. obtaining a population comprising at least one strain of bacteria; b. inoculating a growth medium containing particles with the population comprising at least one strain of bacteria; c. incubating the particles with the population comprising at least one bacterial strain for a time sufficient for the population of at least one strain of bacteria to attach to the particles; and d. culturing the population comprising at least one strain of bacteria attached to the particles in a growth medium, for a time sufficient to form a biofilm.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: May 11, 2021
    Assignee: MYBIOTICS PHARMA LTD.
    Inventors: David Baram, Rachel Diamant, David Daboush
  • Patent number: 10793847
    Abstract: The present invention provides a method, wherein the method forms a biofilm, wherein the biofilm comprises a population of at least one bacterial strain attached to particles, wherein the biofilm is configured to colonize a gut of a subject in need thereof for at least five days, when ingested by the subject, the method comprising: a. obtaining a population comprising at least one strain of bacteria; b. inoculating a growth medium containing particles with the population comprising at least one strain of bacteria; c. incubating the particles with the population comprising at least one bacterial strain for a time sufficient for the population of at least one strain of bacteria to attach to the particles; and d. culturing the population comprising at least one strain of bacteria attached to the particles in a growth medium, for a time sufficient to form a biofilm.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: October 6, 2020
    Assignee: MYBIOTICS PHARMA LTD.
    Inventors: David Baram, Rachel Diamant, David Daboush
  • Patent number: 10709744
    Abstract: Compositions comprising 10% to 50% (w/w) of at least one probiotic bacteria in the form of biofilm, and lipophilic carriers are provided. Further, process for making such compositions and methods of use are provided.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: July 14, 2020
    Assignee: MYBIOTICS PHARMA LTD.
    Inventors: David Daboush, Stephanie Cohen, Dorit Rozner